View in EDS HTML Full Text PDF Full Text

Will cervical screening remain cost-effective in women offered the next generation nonavalent HPV vaccine? Results for four developed countries.

Saved in:
Bibliographic Details
Title: Will cervical screening remain cost-effective in women offered the next generation nonavalent HPV vaccine? Results for four developed countries.
Authors: Simms KT; Cancer Research Division, Cancer Council NSW, Woolloomooloo, Sydney, NSW, Australia.; Prince of Wales Clinical School, The University of New South Wales, Australia., Smith MA; Cancer Research Division, Cancer Council NSW, Woolloomooloo, Sydney, NSW, Australia.; Prince of Wales Clinical School, The University of New South Wales, Australia.; School of Public Health, University of Sydney, Australia., Lew JB; Cancer Research Division, Cancer Council NSW, Woolloomooloo, Sydney, NSW, Australia.; Prince of Wales Clinical School, The University of New South Wales, Australia., Kitchener HC; Institute of Cancer Sciences, University of Manchester, United Kingdom., Castle PE; Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY.; Global Coalition against Cervical Cancer, Arlington, VA., Canfell K; Cancer Research Division, Cancer Council NSW, Woolloomooloo, Sydney, NSW, Australia. karen.canfell@nswcc.org.au.; Prince of Wales Clinical School, The University of New South Wales, Australia. karen.canfell@nswcc.org.au.; School of Public Health, University of Sydney, Australia. karen.canfell@nswcc.org.au.
Source: International journal of cancer [Int J Cancer] 2016 Dec 15; Vol. 139 (12), pp. 2771-2780.
Publication Type: Journal Article
Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1097-0215
DOI:10.1002/ijc.30392